Show simple item record

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study (Ophthalmology and Therapy, (2020), 10.1007/s40123-020-00280-8)

dc.contributor.authorFarooq, Asim V.
dc.contributor.authorDegli Esposti, Simona
dc.contributor.authorPopat, Rakesh
dc.contributor.authorThulasi, Praneetha
dc.contributor.authorLonial, Sagar
dc.contributor.authorNooka, Ajay K.
dc.contributor.authorJakubowiak, Andrzej
dc.contributor.authorSborov, Douglas
dc.contributor.authorZaugg, Brian E.
dc.contributor.authorBadros, Ashraf Z.
dc.contributor.authorJeng, Bennie H.
dc.contributor.authorCallander, Natalie S.
dc.contributor.authorOpalinska, Joanna
dc.contributor.authorBaron, January
dc.contributor.authorPiontek, Trisha
dc.contributor.authorByrne, Julie
dc.contributor.authorGupta, Ira
dc.contributor.authorColby, Kathryn
dc.date.accessioned2020-09-24T17:30:11Z
dc.date.available2020-09-24T17:30:11Z
dc.date.issued2020-09-12
dc.identifier.urihttp://hdl.handle.net/10713/13764
dc.descriptionOriginal article at https://doi.org/10.1007/s40123-020-00280-8en_US
dc.description.abstractThe authors of the above mentioned article would like to highlight the corrections in https://doi.org/10.1007/s40123-020-00289-z, based upon recent changes to the FDA label and guidance on the use of belamaf.en_US
dc.description.urihttps://doi.org/10.1007/s40123-020-00289-zen_US
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofOphthalmology and Therapyen_US
dc.titleCorrection to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study (Ophthalmology and Therapy, (2020), 10.1007/s40123-020-00280-8)en_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s40123-020-00289-z


This item appears in the following Collection(s)

Show simple item record